• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Beta Drugs Limited — Board Meeting, 14-02-2026: Outcome of Board Meeting

    14-02-2026 | 01:36 pm

    Beta Drugs board approved Q3 results. Revenue INR 89.58 Cr, PAT INR 8.51 Cr. Sales flat, but own-brand sales up 33%. FY26 revenue cut to INR 400 Cr (from INR 420 Cr) due to strategic de-focus on lower-margin Platins. Company targets INR 530 Cr in FY27.

    No comments yet. Be the first to comment!

    All announcements from Beta Drugs Limited